On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
On Jul. 22, 2020, In a paper in the New England Journal of Medicine, scientific leaders from the…
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
On Jul. 22, 2020, University of California at Los Angeles researchers reported that they found. levels of antibodies…
On Jul. 22, 2020, the World Health Organization (WHO) and UNICEF announced the COVID-19 Law Lab initiative which…
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
On Jul. 20, 2020, Sorrento received clearance from the U.S. Food and Drug Administration (FDA) to initiate a…
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced it will accept an Indefinite Delivery Indefinite…
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
On Jul. 20, 2020, Pfizer and BioNTech announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 20, 2020, Luminex announced the Food and Drug Administration (FDA) had issued an Emergency Use Authorization…
On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…
On Jul. 18, 2020, with Brazil leading the world in newly diagnosed COVID-19 cases, Latin America has become…
On Jul. 18, 2020, the U.S. Food and Drug Administration (FDA) reissued an emergency use authorization (EUA) to…
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
On Jul. 16, 2020, Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study…
On Jul. 16, 2020, Telesis Bio announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
On Jul. 15, 2020, BD (Becton, Dickinson) announced a commitment from the U.S. Department of Health and Human…
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
On Jul. 15, 2020, a Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19. Published…
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19 nasal spray…
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…